BioPharma News Archive

0

Research and Markets: 2014 US Pharmaceutical Companies Contacts Directory – 2,658 companies & 5000+ Contacts

Research and Markets has announced the addition of the "US Pharmaceutical Companies Contacts Directory" direct
0

La Jolla Pharmaceutical Company Announces Pricing of Underwritten Offering of Common Stock

La Jolla Pharmaceutical Company , a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced the pricing of an underwritten offering of 4,800,000 shares of its common stock, offered at a price of $10.50 per share.
0

Camargo Strengthens Research Team and Therapeutic Expertise

Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505 approval pathway, expands its research team and therapeutic expertise with the addition of Dr.
0

ISPE Annual Meeting – Preview

As the pharmaceutical landscape evolves,industry professionals are being askedto overcome an increasing number ofchallenges and accomplish more today.
0

Research and Markets: Pipeline Analysis and Sales Projections of the Top 25 Pharmaceutical Companies 2013-2023

Research and Markets has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Project
0

Pharmaceutical firm in £14m profits

The pharmaceutical company owned by the late Lord Ballyedmond made pre-tax profits of just under £14m in 2013.
0

Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP

Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho"), a fully-fledged oncology pharmaceutical company, announced on July 23 that the company will be investing US$30 million in Remiges BioPharma Fund (hereinafter "Remiges Fund"), a newly formed biotech venture capital fund. Taiho has a long history of developing new therapeutic options to serve the needs of oncologists and cancer patients. At the ...
0

La Jolla Pharmaceutical Company Announces Proposed Underwritten Offering of Common Stock

La Jolla Pharmaceutical Company , a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to its existing shelf registration statement.
0

Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and …

NEW YORK, July 22, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical ...
0

CTD Holdings Closes $1.725 Million Private Placement

CTD Holdings, Inc. , a manufacturer and distributor of cyclodextrins for the pharmaceutical, medical device, cosmetics, and other markets, announced today that it has closed on a Private Placement with ...
Page 1 of 39712345...102030...Last »